300. IgG4-related disease Clinical trials / Disease details
Clinical trials : 40 / Drugs : 47 - (DrugBank : 21) / Drug target genes : 18 - Drug target pathways : 141
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT05746689 (ClinicalTrials.gov) | March 1, 2023 | 13/2/2023 | Study of Sirolimus in IgG4-related Disease | Combination Therapy of Sirolimus and Glucocorticoids for the Maintenance of Remission in Patients With IgG4-related Disease | IgG4-related Disease | Drug: Sirolimus | Peking University International Hospital | NULL | Not yet recruiting | 18 Years | 80 Years | All | 20 | N/A | NULL |